BC
BIO icon

Burney Company’s Bio-Rad Laboratories Class A BIO Stock Holding History

Burney Company’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-330
Closed -$249K – 572
2021
Q4 		$249K Buy
330
+5
+2% +$3.74K 0.01% 534
2021
Q3 		$242K Sell
325
-13
-4% -$9.74K 0.01% 524
2021
Q2 		$218K Buy
+338
New +$206K 0.01% 559
2020
Q2 		– Sell
-1,410
Closed -$494K – 485
2020
Q1 		$494K Sell
1,410
-10
-0.7% -$3.68K 0.04% 301
2019
Q4 		$525K Buy
1,420
+28
+2% +$9.87K 0.03% 330
2019
Q3 		$463K Sell
1,392
-185
-12% -$60.4K 0.03% 325
2019
Q2 		$493K Buy
+1,577
New +$472K 0.03% 324

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Burney Company's BIO Position: Q1 2022 in Review

Burney Company sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2022, closing a stake of 330 shares — an estimated $249K sold.

Burney Company first reported a position in BIO in Q2 2019 and held it in 7 quarters. The position peaked at $525K in Q4 2019. 514 funds tracked by Wall St. Rank hold BIO as of Q1 2022.

  • Burney Company reported no remaining Bio-Rad Laboratories Class A position as of Q1 2022 after selling out during the quarter.
  • Burney Company sold 330 Bio-Rad Laboratories Class A shares in Q1 2022, an estimated $249K.
  • Burney Company first reported a position in Bio-Rad Laboratories Class A in Q2 2019 and held it in 7 quarters.
  • Burney Company's Bio-Rad Laboratories Class A position peaked at $525K in Q4 2019.
  • 514 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2022.

Based on Burney Company's 13F filing for Q1 2022, filed 9 May 2022.